RDY
Dr. Reddy’s Laboratories Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$11.05B
P/E Ratio
18.14
EPS
$0.73
Beta
0.30
52W High
$16.07
52W Low
$12.70
50-Day MA
$14.01
200-Day MA
$14.14
Dividend Yield
0.71%
Profit Margin
16.40%
Forward P/E
24.04
PEG Ratio
3.64
About Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
Fundamentals
| Revenue (TTM) | $345.83B |
| Gross Profit (TTM) | $190.84B |
| EBITDA | $84.79B |
| Operating Margin | 16.40% |
| Return on Equity | 16.10% |
| Return on Assets | 7.96% |
| Revenue/Share (TTM) | $69.37 |
| Book Value | $4.78 |
| Price-to-Book | 2.78 |
| Price-to-Sales (TTM) | 0.03 |
| EV/Revenue | 2.888 |
| EV/EBITDA | 10.43 |
| Quarterly Earnings Growth (YoY) | -14.30% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $832.60M |
| Float | $599.19M |
| % Insiders | 0.00% |
| % Institutions | 13.43% |
Analyst Ratings
Consensus ($14.15 target)
2
Buy2
Hold1
SellData last updated: 4/9/2026